Incidence and prevalence of coccidioidomycosis in patients with end-state liver disease

Janis E. Blair, Vijayan Balan, David D. Douglas, Joseph G. Hentz

Research output: Contribution to journalArticlepeer-review

19 Scopus citations


Coccidioidomycosis is an endemic fungal infection of the desert southwestern United States. Patients with end-stage liver disease (ESLD) have not been described as having a high rate of coccidioidal infection. We prospectively evaluated 290 patients with ESLD for liver transplantation and found that 6 of these patients (2.1%) had active coccidioidal infection at presentation. Of 184 patients listed for transplantation, 48 patients were observed for at least 1 year; among these 48 patients, new coccidioidal infection developed in 2 patients within the year, for a 1-year incidence of 4.2%. Conversely, the incidence of coccidioidal infection in Maricopa County, Arizona in that same period was 0.04%. Awareness is needed to identify the presence of coccidioidal infection, which may be masked by symptoms and findings of ESLD. Treatment may alleviate some of the symptoms of coccidioidomycosis originally attributed to the concomitant liver disease.

Original languageEnglish (US)
Pages (from-to)843-850
Number of pages8
JournalLiver Transplantation
Issue number8
StatePublished - Aug 1 2003

ASJC Scopus subject areas

  • Surgery
  • Hepatology
  • Transplantation


Dive into the research topics of 'Incidence and prevalence of coccidioidomycosis in patients with end-state liver disease'. Together they form a unique fingerprint.

Cite this